title: Comparative Effects of Preoperative Angiotensin-converting Enzyme In-hibitor, Statin and Beta-blocker Treatment on Human Internal Mammary Artery Reactivity in Patients with Coronary Artery Disease: A Pilot Study.
abstract: OBJECTIVE
  We investigated the effect of angiotensin-converting enzyme (ACE)- inhibitor, statin, and beta-blocker usage before coronary bypass surgery (CABG) on vascular reactivity of the internal mammary artery (IMA).
  
  
  METHODS
  Patients, who underwent elective CABG were evaluated. Samples of IMA obtained from 22 patients were divided into 4 groups in respect of drugs used by patients before bypass surgery (control group, ACE inhibitor + statin group, ACE inhibitor + statin + beta-blocker group, and ACE inhibitor + beta-blocker group). The discarded, distal end section of IMA was carefully removed, and the vasoreactivity of IMA rings was evaluated in vitro using an organ chamber. Smooth muscle contractile function was tested on artery segments exposed to 10-80 mM KCl and norepinephrine. The endothelial function of IMA rings was assessed with acetylcholine (ACh) and bradykinin, while endothelium-independent vasorelaxation was evaluated by sodium nitroprusside (SNP).
  
  
  RESULTS
  Both ACh and bradykinin caused concentration-dependent relaxation in endothelium-intact IMA rings. However, the maximal effect produced by endothelium-dependent agents in all treatment groups was more prominent when compared with the control group. There was no significant difference in the endothelium-dependent relaxation response of IMA between ACE inhibitor + statin, ACE inhibitor + beta-blocker and ACE inhibitor + statin + beta-blocker groups. The vasodilatory potency of SNP was similar in all groups. Similarly, contractile response to KCl or norepinephrine was not significantly different between groups.
  
  
  CONCLUSIONS
  Use of ACE inhibitors and statins before bypass surgery may influence IMA vasoreactivity by improving endothelial control of vascular tone.
authors.affiliation: Akdeniz University Faculty of Medicine, Department of Pharmacology, 07070, Antalya, Turkey.
authors.forename: Selvinaz
authors.initials: S
authors.lastname: Dalaklioglu
authors.forename: Ilhan
authors.initials: I
authors.lastname: Golbasi
authors.forename: Caglar
authors.initials: C
authors.lastname: Ogutman
keywords: Internal mammary artery; angiotensin-converting enzyme inhibitor.; beta-blocker; endothelium; statin
references.citation: Cardiovasc Res. 2001 Jan;49(1):146-51
references.pmid: 11121806
references.citation: Eur J Pharmacol. 1991 Feb 26;194(1):1-5
references.pmid: 1676370
references.citation: Circulation. 2000 Apr 25;101(16):1899-906
references.pmid: 10779454
references.citation: Am J Physiol Heart Circ Physiol. 2004 Apr;286(4):H1425-32
references.pmid: 14644762
references.citation: Am J Cardiol. 2000 Nov 15;86(10):1128-30, A6
references.pmid: 11074212
references.citation: Mol Biol Rep. 2011 Aug;38(6):3821-8
references.pmid: 21107720
references.citation: Br J Pharmacol. 2001 Aug;133(8):1330-8
references.pmid: 11498519
references.citation: Am J Cardiol. 2002 Nov 21;90(10C):40L-48L
references.pmid: 12459427
references.citation: Basic Clin Pharmacol Toxicol. 2012 Nov;111(5):309-16
references.pmid: 22703478
references.citation: Cardiovasc Hematol Agents Med Chem. 2009 Jul;7(3):212-22
references.pmid: 19689260
references.citation: Hypertension. 2003 Jun;41(6):1281-6
references.pmid: 12719441
references.citation: Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):704-16
references.pmid: 21450596
references.citation: Heart Lung Circ. 2005 Mar;14(1):13-8
references.pmid: 16352246
references.citation: J Cardiovasc Pharmacol. 1993 Mar;21(3):484-8
references.pmid: 7681512
references.citation: Am J Cardiol. 1994 Nov 1;74(9):901-5
references.pmid: 7526676
references.citation: Thromb Haemost. 2004 Jun;91(6):1065-77
references.pmid: 15175791
references.citation: Circulation. 2004 Jun 15;109(23 Suppl 1):III39-43
references.pmid: 15198965
references.citation: Med Pregl. 2006 Jul-Aug;59(7-8):335-41
references.pmid: 17140033
references.citation: Cardiology. 1993;82 Suppl 3:19-23
references.pmid: 8106159
references.citation: Hypertension. 1999 Jan;33(1 Pt 2):467-71
references.pmid: 9931149
references.citation: J Am Osteopath Assoc. 2001 Sep;101(9 Suppl):S6-11
references.pmid: 11575043
references.citation: Lancet. 2003 Sep 6;362(9386):782-8
references.pmid: 13678872
references.citation: J Endocrinol Invest. 2007 Oct;30(9):726-33
references.pmid: 17993763
references.citation: Ann Thorac Surg. 2001 Oct;72(4):1290-7
references.pmid: 11603450
references.citation: J Thorac Cardiovasc Surg. 2001 Mar;121(3):431-3
references.pmid: 11241076
references.citation: Atherosclerosis. 2001 Jan;154(1):87-96
references.pmid: 11137086
references.citation: Circulation. 2000 Mar 7;101(9):948-54
references.pmid: 10704159
references.citation: Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):61-9
references.pmid: 10634801
references.citation: Clin Sci (Lond). 2005 Apr;108(4):331-8
references.pmid: 15574127
references.citation: Curr Vasc Pharmacol. 2012 May;10(3):378-90
references.pmid: 22022769
references.citation: N Engl J Med. 2000 Jan 20;342(3):145-53
references.pmid: 10639539
references.citation: Br J Anaesth. 2004 Jul;93(1):105-13
references.pmid: 15121728
references.citation: J Hypertens. 2007 Feb;25(2):361-6
references.pmid: 17211242
references.citation: Int J Cardiol. 2012 Apr 5;156(1):55-61
references.pmid: 21093076
references.citation: Am J Hypertens. 2007 Apr;20(4):443-50
references.pmid: 17386354
references.citation: Nature. 1993 Apr 29;362(6423):801-9
references.pmid: 8479518
references.citation: Circulation. 2004 Sep 14;110(11 Suppl 1):II45-9
references.pmid: 15364837